Searching for targets for the systemic therapy of mesothelioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Searching for targets for the systemic therapy of mesothelioma

Published:2015-08 Issue:8 Volume:26 Page:1649-1660
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Stahel R.A.,Weder W.,Felley-Bosco E.,Petrausch U.,Curioni-Fontecedro A.,Schmitt-Opitz I.,Peters S.

Funder

Stiftung für Angewandte Krebsforschung

Krebsliga Zürich

Swiss National Science Foundation

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/26/8/1649/5024769/mdv101.pdf

Reference111 articles.

1. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003

2. Multimodal management of malignant pleural mesothelioma: where are we today?;Van Schil;Eur Respir J,2014

3. Hippo/YAP pathway for targeted therapy;Felley-Bosco;Transl Lung cancer Res,2014

4. Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition;Johnson;J Clin Invest,2010

5. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma;Bott;Nat Genet,2011

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesothelin expression remodeled the immune-matrix tumor microenvironment predicting the risk of death in patients with malignant pleural mesothelioma;Frontiers in Immunology;2023-10-12

2. Malignant Peritoneal Mesothelioma: An In-Depth and Up-to-Date Review of Pathogenesis, Diagnosis, Management and Future Directions;Cancers;2023-09-25

3. Mesothelioma Due to Workplace Exposure: A Comprehensive Bibliometric Analysis of Current Situation and Future Trends;International Journal of Environmental Research and Public Health;2023-02-06

4. Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project;Modern Pathology;2022-12

5. Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks;Biomolecules;2022-06-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3